Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Afatinib

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCTHO1684

    07/20/2017

    Phase I Trial of Combination Afatinib and Necitumumab in EGFR Mutation Positive NSCLC with Acquired Resistance to First or Third Generation EGFR TKIs

    Treatment

    ECOGEAY131-M

    07/16/2015

    Molecular Analysis for Therapy Choice


    Print this page for your doctor